Study of BMS-986315 Alone and in Combination With Nivolumab or Cetuximab in Participants With Advanced Solid Tumors
Phase 1/2 Completed
44 enrolled 22 charts
A Study of BMS-986466 With Adagrasib With or Without Cetuximab in Participants With Kirsten Rat Sarcoma Virus Glycine 12 to Cysteine (KRAS G12C)-Mutant Solid Tumors
Phase 1/2 Terminated
5 enrolled 9 charts
GSK3359609 Plus Tremelimumab for the Treatment of Advanced Solid Tumors
Phase 1/2 Completed
26 enrolled 47 charts
Cetuximab in Treating Patients With Recurrent or Stage IIIB or Stage IV Lung Cancer
Phase 2 Completed
72 enrolled 9 charts
S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
Phase 3 Terminated
1,333 enrolled 22 charts
High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
Phase 3 Completed
544 enrolled 21 charts
Study of Avelumab and Cetuximab Plus Gemcitabine and Cisplatin in Participants With NSCLC
Phase 2 Completed
43 enrolled 18 charts
A Study of LY3499446 in Participants With Advanced Solid Tumors With KRAS G12C Mutation
Phase 1/2 Terminated
5 enrolled 9 charts
Chemoradiotherapy in Stage III Non-small Cell Lung Cancer (NSCLC)
Phase 2 Completed
106 enrolled 13 charts
A Study of IMC-A12 (Cixutumumab) With and Without Other Standard Chemotherapies in Participants With Lung Cancer Who Have Not Received Chemotherapy Before
Phase 2 Completed
64 enrolled 20 charts
Ph II of Vinflunine and Cetuximab in Second Line Treatment of NSCLC
Phase 2 Terminated
18 enrolled 7 charts
Erlotinib and Cetuximab in Treating Patients With Advanced Solid Tumors With Emphasis on Non-Small Cell Lung Cancer
Phase 1/2 Completed
64 enrolled 11 charts
CERTO
Phase 2 Completed
232 enrolled 17 charts
Efficacy/Safety of Imprime PGG With Cetuximab & Paclitaxel/Carboplatin Therapy in Pts With Untreated Advanced Non-Small Cell Lung Cancer
Phase 2 Completed
90 enrolled 20 charts
Pemetrexed Disodium, Carboplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III Non-Small Cell Lung Cancer
Phase 2 Completed
109 enrolled 12 charts
Pemetrexed Plus Cetuximab in Patients With Recurrent Non Small Cell Lung Cancer
Phase 1/2 Completed
36 enrolled 12 charts
A Safety Study of MM-121 With Cetuximab and Irinotecan in Patients With Advanced Cancers
Phase 1 Completed
48 enrolled 14 charts
Cetuximab and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer
Phase 2 Completed
58 enrolled 8 charts
Study of Taxane/Carboplatin +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer
Phase 3 Completed
755 enrolled 26 charts
Safety Study of Cetuximab in Combination With Cisplatin and Vinorelbine to Treat Advanced Non-small Cell Lung Cancer
Phase 2 Completed
72 enrolled 15 charts
Cetuximab Plus Conformal Thoracic Radiotherapy in Patients (Pts) With Inoperable or Unresectable Locally Advanced Non-Small Cell Lung Cancer (LA - NSCLC)
Phase 2 Completed
27 enrolled 8 charts
Trial of BIBW 2992 (Afatinib) + Cetuximab in Non-Small Cell Lung Cancer
Phase 1 Completed
171 enrolled 23 charts
S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer
Phase 2 Completed
110 enrolled 8 charts
A Study of Induction and Maintenance Treatment of Advanced or Metastatic Non Squamous Non-Small Cell Lung Cancer
Phase 2 Completed
113 enrolled 14 charts
Carboplatin and Paclitaxel Combined With Cetuximab and/or IMC-A12 in Patients With Advanced Non-Small Cell Lung Cancer
Phase 2 Completed
140 enrolled 9 charts
FLEX
Phase 3 Completed
1,861 enrolled 15 charts
NEXT
Phase 3 Completed
583 enrolled 15 charts
Trial Comparing Cetuximab With Pemetrexed/Cetuximab Therapy for Non-Small Cell Lung Cancer
Phase 2 Terminated
55 enrolled 10 charts
S0429: Docetaxel, Cetuximab, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer
Phase 1 Terminated
24 enrolled 10 charts
Gemcitabine, Docetaxel, and Cetuximab in Patients With Unresectable Advanced Non-Small Cell Lung Cancer
Phase 2 Completed
69 enrolled 9 charts
Docetaxel or Pemetrexed With or Without Cetuximab in Patients With Recurrent or Progressive Non-Small Cell Lung Cancer
Phase 3 Completed
939 enrolled 21 charts
Cetuximab as Therapy for Recurrent Non-Small Cell Lung Cancer Patients Who Have Received Prior Therapy
Phase 2 Terminated
56 enrolled 6 charts